Key Events This Week
3 Aug: Significant open interest surge amid mixed price action
4 Aug: Upgraded to Strong Buy on robust financials and bullish technicals
7 Aug: Reports positive financial momentum despite moderation in growth metrics
7 Aug: Sharp open interest surge amid mixed price and volume patterns
3 August: Open Interest Surges Amid Price Weakness
On 3 August 2026, Lupin Ltd. witnessed a notable 13.55% increase in open interest in its derivatives segment, rising from 23,220 to 26,367 contracts. This surge accompanied a futures volume of 12,353 contracts and a combined futures and options traded value nearing ₹27,995 lakhs, signalling robust market participation despite the stock’s price decline.
The stock closed at Rs.2,376.00, down 1.57% from the previous close, underperforming the Sensex which gained 0.82%. Technical indicators showed mixed signals: while the stock remained above its 50-day, 100-day, and 200-day moving averages, it traded below its 5-day and 20-day averages, reflecting short-term weakness amid longer-term support.
Investor delivery volumes increased by 12.52% to 6.99 lakh shares, indicating genuine investor interest beyond speculative trading. The surge in open interest suggested new positions were being established, possibly reflecting hedging or directional bets amid consolidation.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
4 August: Upgrade to Strong Buy on Financial and Technical Strength
MarketsMOJO upgraded Lupin Ltd.’s rating from Buy to Strong Buy on 3 August 2026, reflecting robust financial performance and bullish technical indicators. The company reported record quarterly net sales of ₹7,474.66 crores and a PAT of ₹1,560.39 crores, with operating margins at 34.70% and ROCE at 27.06% for the half-year period.
Lupin’s valuation metrics were attractive, with a Price to Book ratio of 4.8 and a low PEG ratio of 0.3, indicating undervaluation relative to earnings growth. The stock had delivered a one-year return of 27.37%, significantly outperforming the BSE500 index’s 3.90% return.
Technical momentum shifted to bullish, supported by positive MACD signals on weekly and monthly charts, despite mixed RSI readings. Institutional ownership remained strong at 47.07%, underscoring confidence from large investors. Despite the upgrade, the stock closed the day at Rs.2,376.00, down 1.57%, reflecting short-term profit-taking or market caution.
5-6 August: Modest Gains Amid Market Fluctuations
On 5 August, Lupin’s stock price edged up by 0.42% to Rs.2,386.00, with the Sensex also gaining 0.38%. The following day, the stock added a further 0.23% to close at Rs.2,391.50, marking the week’s high. These modest gains occurred amid continued mixed technical signals and stable derivatives activity, suggesting cautious optimism among investors.
Curious about Lupin Ltd. from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
7 August: Positive Financial Momentum Amid Open Interest Surge
Lupin Ltd. reported record quarterly net sales of ₹8,276.89 crores for the quarter ended June 2026, alongside a 49.40% surge in PAT to ₹2,975.39 crores over six months. Despite a moderation in the financial trend score from 24 to 19, the company maintained strong profitability and an all-time high operating profit to interest coverage ratio of 22.34 times.
Cash and cash equivalents stood at ₹5,652.90 crores, providing ample liquidity for strategic initiatives. The stock closed at Rs.2,360.00 on 7 August, down 1.32% from the previous day, underperforming the Sensex which declined 0.21%. The week ended with Lupin’s stock down 2.23%, contrasting with the Sensex’s 1.13% gain.
Open interest in derivatives surged sharply by 28.8% to 38,484 contracts, with futures and options value reaching approximately ₹81,212 lakhs. This increase in open interest amid falling delivery volumes suggests speculative and institutional repositioning, possibly anticipating a significant price move.
Technically, Lupin remains supported by its 100-day and 200-day moving averages but trades below shorter-term averages, indicating subdued near-term momentum. The mixed signals and elevated derivatives activity highlight a complex market environment requiring close monitoring.
Daily Price Comparison: Lupin Ltd. vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-03 | Rs.2,376.00 | -1.57% | 36,985.17 | +0.82% |
| 2026-08-04 | Rs.2,376.00 | +0.00% | 36,933.47 | -0.14% |
| 2026-08-05 | Rs.2,386.00 | +0.42% | 37,074.66 | +0.38% |
| 2026-08-06 | Rs.2,391.50 | +0.23% | 37,177.57 | +0.28% |
| 2026-08-07 | Rs.2,360.00 | -1.32% | 37,099.57 | -0.21% |
Key Takeaways
Positive Signals: Lupin’s record quarterly revenues and profit growth underscore operational strength and efficient capital utilisation, with ROCE at 27.06% and a strong cash position of ₹5,652.90 crores. The upgrade to Strong Buy on 4 August reflected these fundamentals alongside bullish technical momentum. Institutional ownership remains robust at 47.07%, supporting stock stability.
Cautionary Signals: Despite strong fundamentals, the stock underperformed the Sensex by 3.36% over the week, closing down 2.23%. Short-term technical indicators show bearish momentum with prices below key short-term moving averages. The sharp surges in open interest amid declining delivery volumes suggest speculative positioning and potential volatility ahead. The moderation in financial trend score signals a tempered growth pace.
Investors should closely monitor price action relative to moving averages and open interest trends to discern whether Lupin will resume its upward trajectory or face further consolidation.
Conclusion
Lupin Ltd.’s week was characterised by a complex interplay of strong financial results, elevated derivatives activity, and mixed price performance. While the company demonstrated robust revenue and profit growth, alongside a strong liquidity position and institutional backing, the stock’s price declined 2.23% amid cautious technical signals and speculative repositioning in the derivatives market.
The upgrade to Strong Buy early in the week highlighted confidence in Lupin’s fundamentals, but subsequent price softness and a sharp rise in open interest suggest market participants are navigating uncertainty. The stock remains supported by long-term moving averages, yet near-term momentum is subdued.
Overall, Lupin continues to be a significant player in the mid-cap pharmaceutical space with solid operational credentials. However, investors should remain vigilant to evolving market dynamics and technical developments as the stock consolidates amid heightened volatility.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
